Clinical Trial Update: A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of AXS-05 versus bupropion to prevent relapse of depressive symptoms is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• AXS-05 (dextromethorphan-quinidine)
• bupropion (bupropion)

Snippet

Sponsor: Axsome Therapeutics, Inc. | Conditions: Major Depressive Disorder | Phase 4 | Status: RECRUITING